These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8699017)

  • 1. Assessment of variation in trypsin-sensitive neutralizable antigenic site of type O foot-and-mouth disease virus (FMDV) isolates using a Mab-binding inhibition assay.
    Pattnaik B; Jadhao SJ; Venkataramanan R; Mukhopadhyay AK
    J Immunol Methods; 1996 Jun; 192(1-2):191-3. PubMed ID: 8699017
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants.
    Sanyal A; Venkataramanan R; Pattnaik B
    Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis of type O foot-and-mouth disease virus in the persistently infected bovine.
    Salt JS; Samuel AR; Kitching RP
    Arch Virol; 1996; 141(8):1407-21. PubMed ID: 8856023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes on foot-and-mouth disease virus particles. I. Topology.
    McCullough KC; Crowther JR; Carpenter WC; Brocchi E; Capucci L; De Simone F; Xie Q; McCahon D
    Virology; 1987 Apr; 157(2):516-25. PubMed ID: 2435060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C.
    Mateu MG; Da Silva JL; Rocha E; De Brum DL; Alonso A; Enjuanes L; Domingo E; Barahona H
    Virology; 1988 Nov; 167(1):113-24. PubMed ID: 2460992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the trypsin-sensitive antigenic site of foot-and-mouth disease virus following direct binding to an ELISA plate.
    Pattnaik B; Venkataramanan R; Mukhopadhyaya AK
    J Immunol Methods; 1996 Jun; 192(1-2):195-7. PubMed ID: 8699018
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants.
    Crowther JR; Farias S; Carpenter WC; Samuel AR
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1547-53. PubMed ID: 8393912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988.
    Samuel AR; Ouldridge EJ; Arrowsmith AE; Kitching RP; Knowles NJ
    Vaccine; 1990 Aug; 8(4):390-6. PubMed ID: 2168609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.
    Verdaguer N; Sevilla N; Valero ML; Stuart D; Brocchi E; Andreu D; Giralt E; Domingo E; Mateu MG; Fita I
    J Virol; 1998 Jan; 72(1):739-48. PubMed ID: 9420281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response against foot and mouth disease virus (FMDV). Part II: Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12 S virus subunits, VIA and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 Jul; 26(5):358-65. PubMed ID: 93833
    [No Abstract]   [Full Text] [Related]  

  • 14. Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells.
    Meloen RH
    Arch Virol; 1976; 51(4):299-306. PubMed ID: 184763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants.
    Butchaiah G; Morgan DO
    Virus Res; 1997 Dec; 52(2):183-94. PubMed ID: 9495534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
    Mateu MG; Andreu D; Domingo E
    Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
    Das BR; Pattnaik B; Venkataramanan R; Rai DV
    Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production.
    Piatti P; Hassard S; Newman JF; Brown F
    Vaccine; 1995; 13(8):781-4. PubMed ID: 7483796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.